Single Dose Intranasal Oxytocin and Cognitive Effects in Autism

NCT02493426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorders

Interventions

DRUG: Intranasal Oxytocin
DRUG: Placebo

Sponsor

University of Minnesota